TR201908166T4 - Mukozal lezyonların tedavisi için formülasyonlar. - Google Patents

Mukozal lezyonların tedavisi için formülasyonlar. Download PDF

Info

Publication number
TR201908166T4
TR201908166T4 TR2019/08166T TR201908166T TR201908166T4 TR 201908166 T4 TR201908166 T4 TR 201908166T4 TR 2019/08166 T TR2019/08166 T TR 2019/08166T TR 201908166 T TR201908166 T TR 201908166T TR 201908166 T4 TR201908166 T4 TR 201908166T4
Authority
TR
Turkey
Prior art keywords
formulations
mucosal lesions
treatment
mucosal
behçet
Prior art date
Application number
TR2019/08166T
Other languages
English (en)
Inventor
Mehta Raman
Original Assignee
Mehta Raman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mehta Raman filed Critical Mehta Raman
Publication of TR201908166T4 publication Critical patent/TR201908166T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Mevcut buluş Curcuma longa, Punica granatum ve Zingiber officinale'den ekstraktların bir kombinasyonunu içeren, özellikle de Herpes virüsünün veya Behçet sendromunun neden olduğu mukozal lezyonların tedavisi ve önlenmesi için faydalı olan formülasyonlarla ilgilidir. Formülasyonlar özellikle ağız, boğaz ve genital alandaki mukozal lezyonların insidansını azaltmada etkilidir.
TR2019/08166T 2015-06-10 2016-06-10 Mukozal lezyonların tedavisi için formülasyonlar. TR201908166T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15171355.9A EP3103465A1 (en) 2015-06-10 2015-06-10 Formulations for the treatment of mucosal lesions

Publications (1)

Publication Number Publication Date
TR201908166T4 true TR201908166T4 (tr) 2019-06-21

Family

ID=53385534

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/08166T TR201908166T4 (tr) 2015-06-10 2016-06-10 Mukozal lezyonların tedavisi için formülasyonlar.

Country Status (14)

Country Link
US (1) US10786540B2 (tr)
EP (2) EP3103465A1 (tr)
JP (1) JP6830482B2 (tr)
KR (1) KR20180030482A (tr)
CN (1) CN108012530B (tr)
AU (1) AU2016276144B2 (tr)
BR (1) BR112017026422B1 (tr)
ES (1) ES2728557T3 (tr)
HU (1) HUE045225T2 (tr)
MX (1) MX2017016029A (tr)
PL (1) PL3307292T3 (tr)
PT (1) PT3307292T (tr)
TR (1) TR201908166T4 (tr)
WO (1) WO2016198942A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023037299A1 (en) * 2021-09-09 2023-03-16 Integria Healthcare (Australia) Pty Limited Anti-inflammatory compositions comprising ginger and turmeric

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166435B2 (en) * 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
US6596313B2 (en) 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
MXPA05001051A (es) * 2002-08-06 2005-04-08 The Quigley Corp Composiciones anti-microbianas y metodos para usar las mismas.
US7175987B2 (en) * 2002-08-06 2007-02-13 The Quigley Corporation Compositions and methods for treatment of herpes
US20080031979A1 (en) * 2006-08-04 2008-02-07 Claude Saliou Use of extracts for the treatment of viral disorders
US20090175971A1 (en) 2008-01-08 2009-07-09 Mark Dreher Method of using composition comprising pomegranate extracts against the common cold
DE202009002126U1 (de) * 2009-02-13 2009-04-16 Orthomol Pharmazeutische Vertriebs Gmbh Spurenelement enthaltende Zusammensetzung
KR101077920B1 (ko) 2009-07-08 2011-10-31 한국생명공학연구원 울금 추출물을 포함하는 인플루엔자 바이러스 감염의 예방 및 치료용 조성물 및 뉴라미니데이즈 활성의 억제용 조성물
MY152711A (en) * 2009-12-04 2014-11-28 Colgate Palmolive Co Oral compositions containing a combination of natural extracts and related methods
IT1402018B1 (it) 2010-10-11 2013-08-28 Indena Spa Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
JP2013001666A (ja) * 2011-06-14 2013-01-07 Yasuharu Omura 栄養剤組成物
CN102670588B (zh) * 2012-05-04 2013-11-20 中国科学院上海生命科学研究院湖州营养与健康产业创新中心 鞣花酸用于制备抗病毒药物的应用
CN103638502B (zh) * 2013-12-12 2015-07-01 苏振华 一种治疗白塞病的药物及其制备方法
CN103690709B (zh) * 2013-12-14 2016-03-09 青岛市中心医院 一种治疗肠白塞病的中药
CN104524508A (zh) * 2014-12-24 2015-04-22 赵红 一种治疗消化性溃疡的中药及其制备方法
EP3103464A1 (en) * 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of disorders of the mouth, throat and respiratory tract

Also Published As

Publication number Publication date
CN108012530A (zh) 2018-05-08
HUE045225T2 (hu) 2019-12-30
PL3307292T3 (pl) 2020-01-31
AU2016276144A1 (en) 2017-12-21
EP3103465A1 (en) 2016-12-14
MX2017016029A (es) 2018-04-13
CN108012530B (zh) 2021-07-02
WO2016198942A1 (en) 2016-12-15
US20180104301A1 (en) 2018-04-19
US10786540B2 (en) 2020-09-29
JP6830482B2 (ja) 2021-02-17
BR112017026422B1 (pt) 2021-10-05
EP3307292A1 (en) 2018-04-18
AU2016276144B2 (en) 2022-01-13
PT3307292T (pt) 2019-05-31
BR112017026422A2 (pt) 2018-08-21
ES2728557T3 (es) 2019-10-25
JP2018521124A (ja) 2018-08-02
EP3307292B1 (en) 2019-03-13
KR20180030482A (ko) 2018-03-23

Similar Documents

Publication Publication Date Title
MX2021007679A (es) Anticuerpos humanos para hemaglutinina de influenza.
MY196224A (en) Human Antibodies To Ebola Virus Glycoprotein
MA40151A1 (fr) Vaccins de recombinaison fmdv et leurs utilisations
TR201911232T4 (tr) Otoimmünite gelişimine yönelik coriolus versicolorun ekstraktını içeren topikal bileşimler.
MX2015012397A (es) Composiciones y metodos basados en anticuerpos neutralizados suministrados intranasalmente para eficacia terapeutica aumentada.
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
AR059482A1 (es) Uso de supresion inmune local para potenciar terapia viral oncolitica
CY1119633T1 (el) Νεες φαρμακοτεχνικες μορφες αποτελουμενες απο φυτικα εκχυλισματα
MX2018011205A (es) Composiciones utiles en la prevencion y/o tratamiento de trastornos de la cavidad oral, vias aereas superiores y esofago.
TR201908938T4 (tr) Ağız, boğaz ve solunum yolu rahatsızlıklarının tedavisi için formülasyonlar.
WO2011079073A3 (en) Herpes simplex virus vaccines
MX2017003928A (es) Composiciones farmaceuticas de accion prolongada.
PH12019550039A1 (en) Dihydropyrimidine compound and preparation method and use thereof
MX2019004029A (es) Compuestos y metodos para diagnosis y tratamiento de infecciones virales.
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
MY193613A (en) Synergistic composition for osteoarthritis
EA201590678A1 (ru) Соединения для лечения блокады ремиелинизации при заболеваниях, связанных с экспрессией белка оболочки herv-w
TR201908166T4 (tr) Mukozal lezyonların tedavisi için formülasyonlar.
MX2021000774A (es) Composiciones de curcuminoides.
MY189021A (en) Peptides and uses therefor as antiviral agents
PH12020551051A1 (en) Human antibodies to influenza hemagglutinin
MA40805A (fr) Compositions pharmaceutiques à action prolongée contre l'hépatite c
PH12017501943B1 (en) Influenza virus neutralizing peptidomimetic compounds
TR201721700A2 (tr) Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari
MX2022004570A (es) Vacunas contra el virus de la gripe y usos de estas.